NASH Clinical Trials 2024 Key Phase 3 Trial Updates and Future Approvals 2025
The Race to Regulatory Submission The year 2024 is proving to be a watershed moment for NASH Clinical Trials, with several long-running Phase 3 studies expected to read out key data and announce regulatory submissions. The pipeline of therapeutic candidates is diverse, covering multiple mechanistic targets, including metabolism, inflammation, and fibrosis. The success of these trials is defined...
0 Comentários 0 Compartilhamentos 3 Visualizações 0 Anterior